Novel Ways of Using Immunoglobulin to Treat Disabling Neurological Disorders Are Being Explored

Researchers are targeting autoimmune epilepsy and chronic inflammatory demyelinating polyneuropathy.

By Karen MacPhail and Gabriela Espinoza, MD

July 25th, 2017

As many as one billion people worldwide suffer from more than 600 neurological disorders, according to the World Health Organization and University of California, San Francisco, respectively. Of that number, it is estimated that 6.8 million people die each year from neurological disorders ranging from epilepsy to Alzheimer’s disease.

Neurological disorders affect the central nervous systems or the peripheral nervous systems and can impair the brain, spinal cord, peripheral nerve or neuromuscular function.

Continue reading

Share
Posts represent the opinion of the author and do not necessarily reflect the views of CSL Behring.
This site is not intended as a forum for discussing CSL Behring or other companies' products.
Comments on this blog may be reviewed by CSL Behring and may be subject to removal if they are deemed to have inappropriate content.